CARBOPLATIN AND CYCLOPHOSPHAMIDE SALVAGE THERAPY FOR OVARIAN-CANCER PATIENTS RELAPSING AFTER CISPLATIN COMBINATION CHEMOTHERAPY

被引:39
作者
VANDERBURG, MEL
HOFF, AM
VANLENT, M
RODENBURG, CJ
VANPUTTEN, WLJ
STOTER, G
机构
[1] DANIEL DE HOED KLIN,ROTTERDAM CANC INST,DEPT GYNECOL ONCOL,3008 AR ROTTERDAM,NETHERLANDS
[2] DANIEL DE HOED KLIN,ROTTERDAM CANC INST,DEPT BIOSTAT,3008 AE ROTTERDAM,NETHERLANDS
关键词
D O I
10.1016/0277-5379(91)90507-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
30 ovarian cancer patients with a relapse after prior cisplatin combination chemotherapy were treated in a phase II study with cyclophosphamide 100 mg/m2 orally on days 1-7 and carboplatin 300 mg/m2 intravenously on day 8. Treatment was well tolerated. The major side-effect was thrombocytopenia. 28 patients were evaluable for response. The response was 5 CRs (18%), 4 PRs (14%) 15 SDs (53%) and 4 PDs (14%), for an overall response rate of 32%. The overall progression-free survival lasted from 2 to 23 months, median 8 months. Overall survival ranged from 2 to 35+ months , median 12 months. Patients with a therapy-free interval of more than 1 year showed a higher response rate (46%) than patients with a shorter therapy-free interval (20%). It is concluded that platinum containing second-line chemotherapy, after treatment that already contained cisplatin, is only warranted to palliate symptoms.
引用
收藏
页码:248 / 250
页数:3
相关论文
共 26 条
[1]  
BRUCKNER HW, 1981, CANCER, V47, P2288, DOI 10.1002/1097-0142(19810501)47:9<2288::AID-CNCR2820470931>3.0.CO
[2]  
2-3
[3]  
COLOMBO N, 1989, 2ND P IGCS M, P130
[4]  
COPELAND LJ, 1986, OBSTET GYNECOL, V68, P873
[5]  
DECKER DG, 1982, OBSTET GYNECOL, V60, P481
[6]  
EDMONSON JH, 1985, CANCER TREAT REP, V69, P1243
[7]  
EVANS BD, 1983, CANCER TREAT REP, V67, P997
[8]   MOVING-STRIP ABDOMINO-PELVIC RADIOTHERAPY AFTER CIS-PLATINUM-BASED CHEMOTHERAPY AND 2ND-LOOK OPERATION - A FEASIBILITY STUDY IN ADVANCED OVARIAN-CANCER [J].
FALCONE, A ;
CHIARA, S ;
FRANZONE, P ;
VITALE, V ;
SCARPATI, D ;
BRUZZONE, M ;
CARNINO, F ;
CONTE, PF .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (01) :16-20
[9]   CARBOPLATIN IN COMBINATION THERAPY FOR OVARIAN-CANCER [J].
HUININK, WWT ;
VANDERBURG, MEL ;
VANOOSTEROM, AT ;
NEIJT, JP ;
GEORGE, M ;
GUASTALLA, JP ;
VEENHOF, CHN ;
ROTMENSZ, N ;
DALESIO, O ;
VERMORKEN, JB .
CANCER TREATMENT REVIEWS, 1988, 15 :9-15
[10]  
KAVANAGH JJ, 1989, SEMIN ONCOL, V16, P45